Forecast sales of top psoriasis treatments worldwide 2019-2026
For 2026, it is forecasted that around 4.8 billion U.S. dollars worth of Novartos' Cosentyx will be sold worldwide, compared to Skyrizi by AbbVie with 4.4 billion U.S. dollars worth of forecasted ales in the same year. This statistic illustrates the forecasted sales of the leading psoriasis treatments from 2019 to 2026.